Market Research Logo

Kenya Pharmaceuticals and Healthcare Report Q2 2016

Kenya Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Drugmaker revenue earning opportunities in Kenya will continue to be restricted. Someprogress has been made towards addressing equity challenges, but universal coverage - and subsequently adecline in the reliance of out-of-pocket spending - will not be achieved unless the country adopts a systemicapproach to health financing reforms.

Headline Expenditure Projections

Pharmaceuticals: KES73.35bn (USD746mn) in 2015 to KES83.84bn (USD797mn) in 2016; 14.3%growth in local currency terms and 6.8% in US dollar terms.

Healthcare: KES212.59bn (USD2.16bn) in 2015 to KES237.32bn (USD2.26bn) in 2016; 11.6% growthin local currency terms and 4.3% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Kenya 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kenya 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012
2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kenya 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kenya 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2012
2020)
OTC Medicines Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kenya 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kenya 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kenya 2014
2020)
Industry Risk Reward Index
Middle East and Africa Risk/Reward Index Q2 2016
Kenya Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing & Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Kenya 2010
2015)
Table: Healthcare Personnel (Kenya 2010
2015)
Table: Healthcare Activity (Kenya 2010
2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Kenya 1990
2025)
Table: Key Population Ratios (Kenya 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Kenya 1990
2025)
Table: Population By Age Group (Kenya 1990
2025)
Table: Population By Age Group % (Kenya 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report